Patent ID: 11866431
Assignee: VIVACE THERAPEUTICS, INC.
Field: Organic fine chemistry (Chemistry)
Classification: CPC C | IPC C

Claim 3:
4. The compound of claim 1, or a pharmaceutically acceptable salt or a pharmaceutically acceptable solvate thereof, wherein:
each RX is independently hydrogen, halogen, —OR3, —SR3, —CN, —S(═O3)R3, —S(═O)2R3, —N(R3)2, —NR3S(═O)2R3, —NR3C(═O)R3, substituted or unsubstituted C1-C6alkyl, substituted or unsubstituted C1-C6haloalkyl, substituted or unsubstituted C2-C4alkenyl, substituted or unsubstituted C2-C4alkynyl, or substituted or unsubstituted C1-C6heteroalkyl; and
each R3 is independently hydrogen, substituted or unsubstituted C1-C6alkyl, substituted or unsubstituted C1-C6haloalkyl, substituted or unsubstituted C1-C6heteroalkyl, substituted or unsubstituted C3-C10cycloalkyl, or substituted or unsubstituted C2-C10heterocycloalkyl.